Announcement PDF 1 ASX RELEASE 24 April 2026 Sale of China Bird’s Nest Business Highlights ● BP8 enters into agreement to sell its China-based bird’s nest business ● Transaction completes the Company’s strategic pivot to a sole focus on its Indonesia-based seaweed sales and R&D activities ● Removal of a legacy business and associated liabilities The Board of BPH Global Ltd (ASX: BP8) (BP8, BPH Global or Company) a leading commercial seaweed supply and export Company, is pleased to that the Company has entered into an agreement for the sale of its China-based bird's nest business following completion of a comprehensive and strategic operational review. Background The Company’s ongoing strategic, operational review has included an in-depth, thorough review of the ongoing viability of the Company's bird's nest business in Foshan, China. The business has become a significant legacy issue for the Company as it has completed its pivot to focus solely on its Indonesia-based seaweed sales business and its seaweed-related R&D activities. The Board determined that the continued operation of the bird’s nest business was not aligned with the Company’s strategic direction and that divestment represented the most appropriate outcome for shareholders. This transaction marksakeymilestoneinsimplifyingtheCompany’sstructureandcompletingitstransitiontoastreamlined,seaweed- focused business model. Sale Agreement The Company, through its subsidiary SCU (HK) Limited (SCU HK), has entered into an agreement to sell 100% of the equity in Foshan Gedi Shi Biotechnology Co., Ltd. (FoshanCo), the entity through which the China bird’s nest business is operated, to two individual third-party purchasers who are employees and directors of FoshanCo. Key commercial terms are as follows: • Sale structure: Sale of 100% of the equity in the target company. • Consideration: RMB 0, reflecting the target company’s negative net asset position. • Settlement: SCU HK will pay a one-off settlement amount of USD 20,200 to the purchasers in full and final settlement of all historical claims. • Completion: Completion occurs upon registration of the change of shareholders with the relevant Chinese authorities. • Ownership transfer: 76% to one purchaser and 24% to the other purchaser. 2 The divestment removes a non-core business and allows management to focus entirely on advancing the Company’s Indonesia-based seaweed sales operations and its seaweed-related R&D initiatives. The Board considers the transaction to be a positive outcome for the Company, eliminating legacy complexities and positioning BP8 to pursue growth opportunities within its core seaweed business. – ENDS – Authorised for release by: The Board of BPH Global Ltd For further informa8on, please visit our website at www.bphglobal.com or contact the Company Secretary on 03 9088 2049.